9MPW
 
 | |
9RCZ
 
 | |
9RHS
 
 | |
9RHT
 
 | |
9RHX
 
 | |
9RI0
 
 | |
9RI1
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | (4~{R})-~{N}-(3,4-dipropoxyphenyl)-2-oxidanylidene-3,4-dihydro-1~{H}-quinoline-4-carboxamide, 3C-like proteinase nsp5, BROMIDE ION, ... | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-10 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.309 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RI3
 
 | |
9RI4
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | 2-azanyl-~{N}-[(1~{R},2~{S})-2-(4-chloranyl-3-fluoranyl-phenyl)cyclopropyl]-6-nitro-benzamide, 3C-like proteinase nsp5, SODIUM ION | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-11 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.762 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RI5
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | 3C-like proteinase nsp5, SULFATE ION, ~{N}-(2,3-dihydro-1~{H}-inden-2-yl)-2-pyridin-3-yl-~{N}-(thiophen-2-ylmethyl)ethanamide | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-11 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.634 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RI8
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | 3C-like proteinase nsp5, 4-(azetidin-1-yl)-2-isoquinolin-4-yl-thieno[2,3-d]pyrimidine, DIMETHYL SULFOXIDE, ... | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-11 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.781 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RID
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | (2~{R})-2-[2-(benzotriazol-1-yl)ethanoyl-methyl-amino]-2-(3-fluorophenyl)ethanamide, 3C-like proteinase nsp5, SODIUM ION, ... | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-11 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.63 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RIX
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | (4~{R})-~{N}-[2-(1-benzothiophen-3-yl)ethyl]-7-fluoranyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoline-4-carboxamide, 3C-like proteinase nsp5, DIMETHYL SULFOXIDE, ... | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-12 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.73 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RIY
 
 | |
9RIZ
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | (4~{R})-~{N}-(3-cyclopropylphenyl)-2-oxidanylidene-3,4-dihydro-1~{H}-1,8-naphthyridine-4-carboxamide, 3C-like proteinase nsp5 | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-12 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.734 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RJ0
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | 1-(benzimidazol-1-yl)-3-[(4~{S})-6-fluoranyl-3,4-dihydro-2~{H}-thiochromen-4-yl]urea, 3C-like proteinase nsp5, SODIUM ION | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-12 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.709 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RJ3
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | (2~{R})-1-[3-(aminomethyl)-1,2,4-triazol-1-yl]-3-[2,5-bis(chloranyl)phenoxy]propan-2-ol, 3C-like proteinase nsp5, CHLORIDE ION, ... | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-12 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.618 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RJ5
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | 1-(2-cyclohexylethyl)-3-cyclopropyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]urea, 3C-like proteinase nsp5 | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-12 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.25 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RJ7
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | 3C-like proteinase nsp5, 4-fluoranyl-~{N}-(pyridin-3-ylmethyl)-2,3-dihydroindole-1-carboxamide, SODIUM ION | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-12 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.897 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RJ8
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | 3C-like proteinase nsp5, 4-fluoranyl-~{N}-(3-phenoxypropyl)-~{N}-(1,2-thiazol-5-ylmethyl)-2,3-dihydroindole-1-carboxamide | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-12 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.433 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RJF
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | 3-(5-bromanylpyridin-3-yl)-1-[(1~{R})-1-phenylethyl]imidazolidine-2,4-dione, 3C-like proteinase nsp5 | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-12 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.893 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
9RJR
 
 | SARS-CoV-2 with a bound inhibitor | 分子名称: | 1-[[3,4-bis(fluoranyl)phenyl]methyl]-3-(5-bromanylpyridin-3-yl)imidazolidine-2,4-dione, 3C-like proteinase nsp5, SODIUM ION, ... | 著者 | Mac Sweeney, A. | 登録日 | 2025-06-12 | 公開日 | 2025-07-09 | 実験手法 | X-RAY DIFFRACTION (1.705 Å) | 主引用文献 | SARS-CoV-2 with a bound inhibitor To Be Published
|
|
8XTD
 
 | SARS-CoV-2 papain-like-protease (PLpro) in complex with inhibitor Linagliptin | 分子名称: | 8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-d ione, GLYCEROL, Non-structural protein 3 | 著者 | Choudhary, S, Verma, S, Kumar, P, Tomar, S. | 登録日 | 2024-01-10 | 公開日 | 2025-07-16 | 実験手法 | X-RAY DIFFRACTION (2.7 Å) | 主引用文献 | SARS-CoV-2 papain-like-protease (PLpro) in complex with inhibitor Linagliptin To Be Published
|
|
9HFX
 
 | Crystal structure of SARS CoV-2 3CLpro (Mpro) with ALG-097558 | 分子名称: | (1~{S},2~{S},3~{S},6~{R},7~{R})-~{N}-[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-4-[(2~{S})-2-[[2-chloranyl-2,2-bis(fluoranyl)ethanoyl]amino]-3,3-dimethyl-butanoyl]-4-azatricyclo[5.2.1.0^{2,6}]decane-3-carboxamide, 1,2-ETHANEDIOL, 3C-like proteinase nsp5 | 著者 | Tauchert, M.J, Maskos, K, McGowan, D.C, Stoycheva, A.D. | 登録日 | 2024-11-18 | 公開日 | 2025-07-16 | 最終更新日 | 2025-07-23 | 実験手法 | X-RAY DIFFRACTION (1.96 Å) | 主引用文献 | Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro Inhibitor. J.Med.Chem., 68, 2025
|
|
9HFY
 
 | Crystal structure of SARS CoV-2 3CLpro (Mpro) with ALG-097078 | 分子名称: | (3~{S},3~{a}~{S},6~{a}~{R})-2-[(4-methoxy-1~{H}-indol-2-yl)carbonyl]-~{N}-[(2~{S},3~{R})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrole-3-carboxamide, 1,2-ETHANEDIOL, 3C-like proteinase nsp5 | 著者 | Tauchert, M.J, Maskos, K, McGowan, D.C, Stoycheva, A.D. | 登録日 | 2024-11-18 | 公開日 | 2025-07-16 | 最終更新日 | 2025-07-23 | 実験手法 | X-RAY DIFFRACTION (1.282 Å) | 主引用文献 | Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro Inhibitor. J.Med.Chem., 68, 2025
|
|